Zydus Lifesciences receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
The drug will be manufactured at the group’s topical facility at Ahmedabad
The drug will be manufactured at the group’s topical facility at Ahmedabad
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
The rally attracted around 250 riders, including professionals and amateurs.
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Subscribe To Our Newsletter & Stay Updated